Amwill Healthcare Limited, one of India's fastest-growing Dermatology companies, has launched its Initial Public Offering (IPO) to raise ₹ 59.97 Crores through a Book Built Issue. The IPO includes a fresh issue of 44.03 Lakh shares worth ₹ 48.87 Crores and an Offer for Sale (OFS) of 10.00 Lakh shares totaling ₹ 11.1 Crores. The subscription period is set to open on February 5, 2025, and close on February 7, 2025.

The IPO is set to list on the BSE SME exchange, with allotment finalization expected on February 10, 2025, and the listing date tentatively scheduled for February 12, 2025.

Amwill Healthcare IPO Price, Lot Size & Investment Details

The price band for the Amwill Healthcare IPO is fixed at ₹ 105 to ₹ 111 per equity share. The market capitalization at the upper price band stands at ₹ 222.04 Crores.

• Lot size: 1,200 shares

• Minimum retail investment: ₹ 1,33,200 (1 lot)

• Minimum HNI investment: ₹ 2,66,400 (2 lots, 2,400 shares)

Amwill Healthcare IPO Lead Manager & Registrar

• Book Running Lead Manager: Unistone Capital Private Limited

• Registrar: Bigshare Services Private Limited

• Market Maker: Globalworth Securities Limited

Amwill Healthcare IPO GMP Today & Subscription Status

The Grey Market Premium (GMP) for Amwill Healthcare IPO is currently at ₹ 0, indicating a neutral market response before listing. However, GMP trends depend on demand and supply in the unregulated market.

As of 07:00 PM on February 7, 2025, the Amwill Healthcare IPO subscription status showed an overall subscription of 5.49 times, reflecting investor interest.

How to Check Amwill Healthcare IPO Allotment Status?

The Amwill Healthcare IPO allotment status will be available on the Registrar’s website from February 10, 2025. Follow these steps:

• Go to the IPO allotment status page.

• Select Amwill Healthcare Limited IPO.

• Enter Application Number, PAN, or DP Client ID.

• Click Submit to view the status.

Amwill Healthcare IPO Financial Performance

The financials of Amwill Healthcare Limited indicate strong revenue growth:

• Revenue from Operations:

  • FY2024 (Till Sep 30, 2024): ₹ 2,324.71 Lakh

  • FY2024: ₹ 4,428.41 Lakh

  • FY2023: ₹ 3,028.25 Lakh

  • FY2022: ₹ 2,761.54 Lakh

• Profit After Tax (PAT):

  • FY2024 (Till Sep 30, 2024): ₹ 651.66 Lakh

  • FY2024: ₹ 1,253.63 Lakh

  • FY2023: ₹ 311.44 Lakh

  • FY2022: ₹ 257.37 Lakh

The company has reported a steady increase in revenue and profitability, showcasing consistent growth in the dermatology sector.

Key Performance Indicators & Valuation

• Pre-issue EPS: ₹ 8.04

• Post-issue EPS: ₹ 6.27

• Pre-issue P/E Ratio: 13.81x

• Post-issue P/E Ratio: 17.71x

• Industry P/E Ratio: 36x

• Return on Capital Employed (ROCE): 94.16%

• Return on Equity (ROE): 73.06%

Amwill Healthcare IPO Review: Should You Invest?

Considering the valuation, financial growth, and market conditions, the Amwill Healthcare IPO appears to be fairly priced. However, with the GMP at ₹ 0, investors looking for listing gains may want to be cautious. Long-term investors focused on the dermatology sector could explore this IPO for potential future growth.

Use of IPO Proceeds

The net proceeds from the IPO will be used for:

1. Working Capital Requirements: ₹ 2,500 Lakhs

2. Marketing & Brand Building: ₹ 500 Lakhs

3. General Corporate Purposes

Final Thoughts

The Amwill Healthcare IPO presents a growth opportunity in India's dermatology and cosmeceuticals market. While financials show promise, the low GMP suggests cautious optimism. Investors should analyze subscription demand and market trends before investing.

The Upcoming IPOs in this week and coming weeks are Quality Power Electrical Equipmwnt, PS Raj Steels, Voler Car, Maxvolt Energy, Hexaware Technologies, L.K. Mehta, Shanmuga Hospital.

The Current active IPO are Solarium Green, Ajax Engineering, Chandan Healthcare.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Join our Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates.